Get startedLog in
    Picture of GlaxoSmithKline Pharmaceuticals logo

    GLAXO — GlaxoSmithKline Pharmaceuticals News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: GlaxoSmithKline Pharmaceuticals Says Profitability Of Q1FY21 May Be Impacted Due To COVID-19

    Picture of GlaxoSmithKline Pharmaceuticals logoGlaxoSmithKline Pharmaceuticals
    04/06/2020 07:24
    June 4 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
 GLAX.NS :
    * CURRENTLY OPERATING AT ABOUT 70% OF NORMATIVE
MANUFACTURING
LEVELS
    * SEEN SLOWDOWN IN SALES ACROSS THERAPEUTIC AREAS DURING Q1
    * PERFORMANCE & PROFITABILITY OF Q1FY21 MAY BE IMPACTED

Source text for Eikon:  ID:nBSE5xjwmD 
Further company coverage:  GLAX.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on GlaxoSmithKline Pharmaceuticals

    See all news